Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Enfusion Inc’s stock clocked out at $10.10, up 2.12% from its previous closing price of $9.89. In other words, the price has increased by $2.12 from its previous closing price. On the day, 0.51 million shares were traded. ENFN stock price reached its highest trading level at $10.18 during the session, while it also had its lowest trading level at $9.91.
Ratios:
To gain a deeper understanding of ENFN’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 26.89 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 65.19. For the most recent quarter (mrq), Quick Ratio is recorded 3.62 and its Current Ratio is at 3.62. In the meantime, Its Debt-to-Equity ratio is 0.30 whereas as Long-Term Debt/Eq ratio is at 0.22.
On February 28, 2024, Goldman Downgraded its rating to Sell which previously was Neutral and also lowered its target price recommendation from $9 to $8.
JP Morgan Downgraded its Neutral to Underweight on January 30, 2024, whereas the target price for the stock was revised from $11 to $9.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Oct 22 ’24 when Campobasso Matthew sold 674 shares for $8.95 per share. The transaction valued at 6,032 led to the insider holds 53,627 shares of the business.
Campobasso Matthew bought 674 shares of ENFN for $6,031 on Oct 22 ’24. On Sep 10 ’24, another insider, Bastone Bronwen, who serves as the Chief People Officer of the company, sold 3,219 shares for $8.12 each. As a result, the insider received 26,138 and left with 195,694 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ENFN now has a Market Capitalization of 953158208 and an Enterprise Value of 952240896. As of this moment, Enfusion’s Price-to-Earnings (P/E) ratio for their current fiscal year is 385.50, and their Forward P/E ratio for the next fiscal year is 34.89. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.65 while its Price-to-Book (P/B) ratio in mrq is 13.47. Its current Enterprise Value per Revenue stands at 4.879 whereas that against EBITDA is 51.397.
Stock Price History:
Over the past 52 weeks, ENFN has reached a high of $10.45, while it has fallen to a 52-week low of $7.52. The 50-Day Moving Average of the stock is 10.55%, while the 200-Day Moving Average is calculated to be 12.84%.
Shares Statistics:
It appears that ENFN traded 387.26K shares on average per day over the past three months and 598450 shares per day over the past ten days. A total of 88.33M shares are outstanding, with a floating share count of 50.08M. Insiders hold about 46.94% of the company’s shares, while institutions hold 59.36% stake in the company. Shares short for ENFN as of 1730332800 were 1178460 with a Short Ratio of 3.04, compared to 1727654400 on 1770724. Therefore, it implies a Short% of Shares Outstanding of 1178460 and a Short% of Float of 2.5899999.
